Trial Condition(s):
Evaluation of the safety and efficacy of Vardenafil in subjects with Erectile Dysfunction
100541
Not Available
Not Available
Erectile dysfunction (ED) is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. An ideal treatment option should be effective and reliable, have minimal side effects, be simple to use and affordable. The aim of this study was to investigate safety, tolerability and efficacy of vardenafil following a flexible dose treatment schedule in subjects with varying aetiology.
- Men >/= 18 years of age, - ED 6 months or longer - Stable sexual relationship for > 6 month.
- Primary hypoactive sexual desire - History of myocardial infarction, stroke or life-threatening arrhythmia within prior 6 month - Nitrate therapy - Other exclusion criteria apply according to the Summary of Product Characteristics
Locations | |
---|---|
Locations Investigative Site Many locations, Australia | Contact Us: E-mail: [email protected] Phone: Not Available |
Open-label, multi-centre, study to investigate the safety, tolerability and efficacy of flexible doses of vardenafil given on demand in males with erectile dysfunction
Trial Type:
Interventional
Intervention Type:
Drug
Trial Purpose:
Treatment
Allocation:
Non-randomized
Blinding:
Open Label
Assignment:
Single Group Assignment
Trial Arms:
1